Holen Sie sich die Stockscreener-App
340.64
1.63%
5.47
Handel nachbörslich:
340.64
Schlusskurs vom Vortag:
$335.17
Offen:
$343.95
24-Stunden-Volumen:
368.56K
Relative Volume:
1.26
Marktkapitalisierung:
$40.38B
Einnahmen:
$4.98B
Nettoeinkommen (Verlust:
$69.59M
KGV:
655.46
EPS:
0.5197
Netto-Cashflow:
$525.67M
1W Leistung:
-3.72%
1M Leistung:
+9.60%
6M Leistung:
+41.09%
1J Leistung:
+0.00%
1-Tages-Spanne:
$337.10
$345.58
1-Wochen-Bereich:
$322.41
$364.97
52-Wochen-Spanne:
$172.67
$385.22
Beone Medicines Ltd Adr Stock (ONC) Company Profile
Firmenname
Beone Medicines Ltd Adr
Sektor
Branche
Telefon
41-616851900
Adresse
C/O BEONE MEDICINES I GMBH, BASEL
Vergleichen Sie ONC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ONC
Beone Medicines Ltd Adr
|
340.64 | 37.09B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
VRTX
Vertex Pharmaceuticals Inc
|
432.17 | 109.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.61 | 82.75B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.12 | 56.78B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.63 | 56.52B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.51 | 44.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Beone Medicines Ltd Adr Stock (ONC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-24 | Eingeleitet | Truist | Buy |
| 2025-09-18 | Eingeleitet | Barclays | Overweight |
| 2025-04-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-03-03 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-12-03 | Fortgesetzt | Morgan Stanley | Overweight |
| 2024-09-18 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-02-06 | Fortgesetzt | JP Morgan | Overweight |
| 2023-09-12 | Eingeleitet | Macquarie | Outperform |
| 2023-08-17 | Eingeleitet | Jefferies | Buy |
| 2023-07-17 | Eingeleitet | Citigroup | Buy |
| 2023-06-30 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-12 | Eingeleitet | Daiwa Securities | Buy |
| 2022-10-13 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-10-13 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-08-09 | Fortgesetzt | JP Morgan | Overweight |
| 2022-03-17 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-02-07 | Eingeleitet | Deutsche Bank | Buy |
| 2021-10-12 | Eingeleitet | Bernstein | Outperform |
| 2021-10-06 | Hochstufung | CLSA | Underperform → Buy |
| 2021-03-08 | Eingeleitet | China Renaissance | Buy |
| 2021-03-01 | Herabstufung | CLSA | Outperform → Underperform |
| 2020-11-09 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-11-06 | Herabstufung | Maxim Group | Buy → Hold |
| 2020-11-06 | Herabstufung | Piper Sandler | Neutral → Underweight |
Alle ansehen
Beone Medicines Ltd Adr Aktie (ONC) Neueste Nachrichten
16,300 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Acquired by Pinpoint Asset Management Singapore Pte. Ltd. - MarketBeat
Edmond DE Rothschild Holding S.A. Invests $9.93 Million in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines (NASDAQ:ONC) Now Covered by Truist Financial - Defense World
Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewswire Inc.
Barings LLC Buys New Holdings in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Long Corridor Asset Management Ltd Invests $11.50 Million in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
ProShare Advisors LLC Makes New $373,000 Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Artisan Partners Limited Partnership Makes New $65.40 Million Investment in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
Artisan Partners Limited Partnership Makes New $65.40 Million Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Xiaobin Wu Sells 3,991 Shares of BeOne Medicines (NASDAQ:ONC) Stock - MarketBeat
5,088,279 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Purchased by Primecap Management Co. CA - MarketBeat
1,500 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Purchased by Alteri Wealth LLC - MarketBeat
1,500 Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC Purchased by Alteri Wealth LLC - Defense World
KBC Group NV Takes $2.18 Million Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Insider Selling: BeOne Medicines (NASDAQ:ONC) COO Sells $2,286,664.86 in Stock - Defense World
BeOne Medicines (NASDAQ:ONC) COO Xiaobin Wu Sells 10,000 Shares of Stock - MarketBeat
BeOne Medicines (NASDAQ:ONC) COO Xiaobin Wu Sells 6,009 Shares - MarketBeat
Fiera Capital Corp Invests $5.06 Million in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Bank of Montreal Can Makes New $1.93 Million Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Montag A & Associates Inc. Acquires New Stake in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Candriam S.C.A. Makes New Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
1,839 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Purchased by Vestmark Advisory Solutions Inc. - MarketBeat
M&G PLC Invests $41.19 Million in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Greenwoods Asset Management Hong Kong Ltd. Makes New $3.75 Million Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
4,740 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Purchased by Profund Advisors LLC - MarketBeat
ABC Arbitrage SA Takes $836,000 Position in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
ABC Arbitrage SA Takes $836,000 Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Penserra Capital Management LLC Takes Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Fox Run Management L.L.C. Makes New Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines Ltd.Sponsored ADR (ONC) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - MSN
BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Connor Clark & Lunn Investment Management Ltd. Takes Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Y Intercept Hong Kong Ltd Makes New $564,000 Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
RBC Capital Adjusts Price Target on BeOne Medicines to $395 From $374, Maintains Outperform Rating - 富途牛牛
Envestnet Asset Management Inc. Acquires Shares of 62,220 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
5,362 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Purchased by EFG Asset Management North America Corp. - MarketBeat
ETFs Investing in BeOne Medicines Ltd. Sponsored ADR Stocks - TradingView
Asset Management One Co. Ltd. Acquires New Shares in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Asset Management One Co. Ltd. Acquires New Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
Oppenheimer Asset Management Inc. Makes New Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Allianz Asset Management GmbH Acquires Shares of 3,300 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
DekaBank Deutsche Girozentrale Purchases Shares of 13,600 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Yousif Capital Management LLC Invests $368,000 in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Sequoia Financial Advisors LLC Takes Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Vanguard Personalized Indexing Management LLC Takes Position in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
Vanguard Personalized Indexing Management LLC Takes Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Janney Montgomery Scott LLC Takes $373,000 Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Callan Family Office LLC Takes Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
1,002 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Bought by IFP Advisors Inc - MarketBeat
Free cash flow per share of BeOne Medicines Ltd. Sponsored ADR – DUS:49BA - TradingView
Finanzdaten der Beone Medicines Ltd Adr-Aktie (ONC)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.16%
3.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):